Get started
Author

Karishma Gokani

Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK
2020 · Merryn Voysey, Sue Ann Costa Clemens, et al. · The Lancet · 4,613
PDF
Single-dose administration and the influence of the timing of the booster dose on immunogenicity and efficacy of ChAdOx1 nCoV-19 (AZD1222) vaccine: a pooled analysis of four randomised trials
2021 · Merryn Voysey, Sue Ann Costa Clemens, et al. · The Lancet · 1,119
PDF
Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial
2021 · Alasdair P S Munro, Leila Janani, et al. · The Lancet · 642
PDF
Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial
2021 · Xinxue Liu, Robert H Shaw, et al. · The Lancet · 491
PDF
Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial
2021 · Munro, APS, Janani, L, et al. · Sussex Research Online (University of Sussex) · 432
PDF
Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial
2022 · Alasdair P S Munro, Shuo Feng, et al. · The Lancet Infectious Diseases · 175
PDF
Clinical features and management of individuals admitted to hospital with monkeypox and associated complications across the UK: a retrospective cohort study
2022 · Douglas L Fink, Douglas L Fink, et al. · The Lancet Infectious Diseases · 99
PDF
Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2): results of a randomised, double-blind, placebo-controlled, phase 3 trial
2022 · Karin Hardt, An Vandebosch, et al. · The Lancet Infectious Diseases · 83
PDF
COVID-19-related intracranial imaging findings: a large single-centre experience
2020 · V. Sawlani, S. Scotton, et al. · Clinical Radiology · 61
PDF
Effect of priming interval on reactogenicity, peak immunological response, and waning after homologous and heterologous COVID-19 vaccine schedules: exploratory analyses of Com-COV, a randomised control trial
2022 · Robert H Shaw, Xinxue Liu, et al. · The Lancet Respiratory Medicine · 38
Safety and immunogenicity of the inactivated whole-virus adjuvanted COVID-19 vaccine VLA2001: A randomized, dose escalation, double-blind phase 1/2 clinical trial in healthy adults
2022 · Rajeka Lazarus, Christian Taucher, et al. · Journal of Infection · 22
Immunogenicity and safety of inactivated whole virion Coronavirus vaccine with CpG (VLA2001) in healthy adults aged 18 to 55: a randomised phase 1 /2 clinical trial
2021 · Rajeka Lazarus, Christian Taucher, et al. · medRxiv · 11
PDF
A combined ELISA for infection-induced and vaccine-induced mpox antibodies during the clade Ib outbreak in Rwanda: an observational, cross-sectional, clinical validation study
2026 · Jenny Clarke, Jenny Clarke, et al. · The Lancet Infectious Diseases · 1
Safety and immunogenicity of rVSVΔG-ZEBOV-GP vaccination when dosed concurrent with mRNA COVID-19 vaccine booster doses in healthy African adults (EbolaCov): protocol for a phase IV, single-centre, single-blinded, randomised controlled trial
2025 · Karishma Gokani, Alice E Taylor, et al. · BMJ Open · 1
Peritoneal dialysis associated non tuberculous mycobacterial peritonitis at a tertiary care hospital in the UK
2022 · Karishma Gokani, Pretin Davda, et al. · Clinical Infection in Practice · 1
PDF
A clinical accuracy study protocol for a saliva-based point-of-care lateral flow test to assess protective immunity to tetanus (TETANUS study)
2026 · K Gokani, SE Faustini, et al. · BMJ Open
Mpox comprehensive assessment for responsive immunisation in emergency outbreaks (MpoxCARE): study protocol
2026 · Karishma Gokani, Herve Semukunzi, et al. · BMC Infectious Diseases
A case report of fracture-related infection with Metamycoplasma hominis in an immunocompetent patient
2024 · Karishma Gokani, Prabu Balasubramanian, et al. · Journal of Bone and Joint Infection
PDF
Works count: 19
Citation count: 7,789
H-index: 11
I10-index: 12
Year
Topic
Type